Thursday, November 28

‘Physician Spending Is Not the Problem in Healthcare’: What We Heard This Week

Perspectives > > What We Heard This Week– Quotable quotes heard by MedPage Today‘s press reporters

by MedPage Today Staff October 6, 2024

“It’s really, extremely clear that doctor costs is not the issue in health care.”– Jen Brull, MD, president of the American Academy of Family Physicians, talking about suggested payment cuts under the Medicare Physician Fee Schedule.

“The Pap smear is in fact an actually bad test.”– Shae Connor, MD, of UT Erlanger Women’s Oncology in Chattanooga, Tennessee, responding after a self-collection HPV test was authorized for usage in health care settings.

“There is a clear association in between using GLPs and increased dangers of food retention throughout upper endoscopy.”– Ruchi Mathur, MD, of Cedars-Sinai Medical Center in West Hollywood, California, on how GLP-1 receptor agonists can impact stomach treatments.

“The thing that can be done is to choose single embryo transfer, which might lower the threat.”– Ulla-Britt Wennerholm, MD, PhD, of University of Gothenburg in Sweden, on the ramification of the finding of excess hereditary heart flaws in kids born by means of helped reproductive innovation.

“We understand that the majority of people look for medical care prior to suicide efforts.”– Julie Angerhofer, PhD, MPH, of Kaiser Permanente Washington Health Research Institute in Seattle, talking about a screening program in medical care practices that was related to less tried suicides.

“It’s both the frequency and the strength of head effects that are the chauffeurs of the illness.”– Michael Alosco, PhD, of the Boston University CTE Center, on the dose-response relationship in between persistent terrible encephalopathy (CTE) neuropathology and the variety of years and the level of football played.

“We required a method to cover the injectable HIV avoidance drugs … What we didn’t understand was they would move the oral PrEP to Part B at the exact same time.”– Carl Schmid, of the HIV+H epatitis Policy Institute in Washington, D.C., on Medicare modifications for long-acting and oral PrEP.

ยป …
Learn more